Biosimilars Archives - Page 2 of 4 - Express Pharma

HCPs see biosimilars as solution to tackle rising costs: GlobalData

Samsung Biologics partners with Pfizer for manufacturing of biosimilars portfolio

Eminence Business Media hosts sixth edition of Annual Pharma Project & Portfolio Management 2023

Sandoz partners with Just–Evotec Biologics to develop and manufacture multiple biosimilars

Teva and Sandoz make major push to biosimilars

Dr Reddy’s lines up Rs 1,500 crore capex to focus on biosimilars and injectables

Biocon Biologics to acquire Viatris’ biosimilars assets for up to $3.335 billion

CPhI and Informa Pharma Intelligence conclude 3rd Biopharma Conclave

A Superstar marriage?

Cipla takes deal route with Alvotech to enter Australian autoimmune biosimilars market: GlobalData